Market Overview

Benzinga's Top Pre-Market Losers

Related NVO
Novo Nordisk Gets FDA Nod for NovoSeven RT - Analyst Blog
Top 4 Stocks In The Drug Manufacturers-Other Industry With The Highest Dividend Yield
Novo Nordisk Upgraded to 'Buy' (Fox Business)
Related CZR
Markets Little Changed As The Quarter Comes To An End
Macau Gaming Sector Continues To See Mass Gaming Growth On Heels Of Near-Term Risk
Caesars to Close Atlantic City Showboat Casino (Fox Business)

Novo Nordisk A/S (NYSE: NVO) shares dropped 13.43% to $166.36 in pre-market trading. Novo Nordisk shares have surged 40.27% over the past 52 weeks, while the S&P 500 index has gained 12.29% in the same period.

Caesars Entertainment (NASDAQ: CZR) dipped 7.12% to $12.92 in the pre-market session. Caesars Entertainment's trailing-twelve-month ROE is -179.12%.

BlackBerry (NASDAQ: BBRY) shares fell 4.06% to $15.82 in the pre-market trading. Bed BlackBerry's trailing-twelve-month profit margin is -6.90%.

Sarepta Therapeutics (NASDAQ: SRPT) dipped 3.15% to $28 in the pre-market session. Sarepta's PEG ratio is -0.51.

Posted-In: Top Pre-Market LosersNews Movers & Shakers Pre-Market Outlook Markets


Most Popular

Related Articles (CZR + BBRY)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free